Log in for full access to this activity, if you are registered.

Registration Options

Activity Dates: 04/23/2013 - 04/23/2016

This course is closed. Please look for other available products in CPNP University.

Target Audience

If you are a pharmacist, nurse practitioner or other healthcare professional involved in the comprehensive medication management of psychiatric and/or neurological patients, we invite you to participate in this online course.

Session Summary

Delirium is frequently observed in critically ill patients and is associated with deleterious outcomes in the hospital and after discharge, including long-term cognitive dysfunction. Screening for the presence of delirium with a validated tool like the Confusion Assessment Method (CAM) – ICU or the Intensive Care Delirium Screening Checklist (ICDSC) should occur frequently to detect delirium in an effort to reduce the duration. Non-pharmacologic interventions may prevent the occurrence of delirium and must be routinely considered. Substituting the use of traditional sedatives with dexmedetomidine and early ambulation have been shown in large studies to reduce the occurrence and/or duration of delirium. No data support the use of haloperidol for treatment. Limited studies reflect the safety of atypical antipsychotic agents for treatment but lack clear improvement in delirium-related outcomes. The pharmacist is ideally situated to aid in the recognition of delirium, institute pharmacologic and non-pharmacologic prevention mechanisms, minimize sedation, and recommend appropriate treatment including the discontinuation of therapy. Ultimately, the best treatment is prevention which involves a multi-professional multimodal approach. The goals of this session for the attendee are 1) describe the signs and symptoms of delirium and delineate two tools used to identify delirium in critically ill patients; 2) explain the clinical significance and associated outcomes of delirium in critically ill patients; 3) identify risk factors for delirium in critically ill patients; and 4) develop prevention and treatment plans for delirium in the critically ill patient.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (login first)
  • Complete the evaluation at the end of the activity. (login first)
  • Receive a passing grade (60%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)

This course is provided online at cpnp.org and consists of the speaker audio and slides. A PDF file of the slides is also provided and access is available to participants indefinitely although ACPE credit is available only through the course expiration date.

Participants in this course must complete an examination and achieve a score of 60% or greater. Successful completion of the course also requires the completion of a course evaluation. ACPE statements of credit can be retrieved by participants online at cpnp.org immediately upon successful completion of the course.

Faculty Information and Disclosures

Robert MacLaren, PharmD, FCCM, FCCP

View biographical information and disclosures

Learning Objectives

  1. Describe the signs and symptoms of delirium and delineate two tools used to identify delirium in critically ill patients.
  2. Explain the clinical significance and associated outcomes of delirium in critically ill patients.
  3. Identify risk factors for delirium in critically ill patients.
  4. Develop prevention and treatment plans for delirium in the critically ill patient.

Continuing Education Credit and Disclosures

Activity Dates: 04/23/2013 - 04/23/2016
ACPE Contact Hours: 1.0
ACPE Number: 0284-0000-13-014-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This self-study course provides 1.0 contact hours (0.01 CEUs) of knowledge-based continuing education credit from CPNP approved programming. The ACPE universal program number assigned to this course is 0284-000-13-014-L01-P (1.0 contact hours).

ACPE approved contact hours are accepted for ANCC Certification Renewal (see pages 5 and 6): At least 50% (37.5 hours) of your 75 continuing education hours must be formally approved continuing education hours. Formally approved continuing education hours meet one or more of the criteria listed below:

  1. Continuing nursing education (CNE) approved for nursing contact hours by an accredited provider or approver of nursing continuing education
  2. Continuing medical education (CME) approved for CME hours
  3. Sponsored by organizations, agencies, or educational institutions accredited or approved by the American Nurses Credentialing Center (ANCC) or the Accreditation Council for Continuing Medical Education (ACCME) or the Accreditation Council for Pharmacy Education (ACPE) or the Commission on Dietetic Registration

Grant Support

Annual Meeting Grant Provider

Cyberonics